LNTH - Financial Reports List - Lantheus Holdings, Inc. - IntrinsicAlpha

Lantheus Holdings, Inc. LNTH

Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US

$ 95.45

4.98 %

$ 6.54 B

Market Cap

21.89

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	10.48%	-11.40%	-17.18%
Annual Report	FY	10-K	2024-12-31	18.32%	-4.35%	25.32%
Quarterly Report	Q3	8-K	2024-09-30	18.37%	-0.65%	19.03%
Quarterly Report	Q2	8-K	2024-06-30	22.50%	-34.06%	-17.33%
Quarterly Report	Q1	8-K	2024-03-31	23.00%	4769.26%	1174.28%
Quarterly Report	Q4	8-K	2023-12-31	34.52%	186.74%	180.08%
Annual Report	FY	10-K	2023-12-31	38.65%	1063.86%	2813.72%
Quarterly Report	Q3	8-K	2023-09-30	33.71%	115.50%	31.04%
Quarterly Report	Q2	8-K	2023-06-30	43.79%	118.61%	96.41%
Quarterly Report	Q1	8-K	2023-03-31	44.00%	-6.53%	-15.86%

1